As a developing region, Latin America faces unique cancer control and prevention
challenges, which are intensified when considering rare cancers, including sarcomas …

Simple Summary Benchmarking is a crucial tool for healthcare providers to improve quality
and efficiency, especially for complex conditions like sarcomas. Sarcomas are a type of …

About 500,000 patients with rare adult solid cancers (RASC) are diagnosed yearly in
Europe. Delays and unequal quality of management impact negatively their survival. Since …

The landscape of sarcoma care is on the cusp of a transformative era, spurred by the
convergence of digital health and artificial intelligence (AI). This perspectives article …

Epithelioid hemangioendothelioma: a nationwide study Epithelioid hemangioendothelioma
(EHE) is an ultrarare sarcoma whose natural history and treatment is not well defined. We …

Background We investigated the impact of the implementation of a network of reference
centers for sarcomas (NETSARC) on the care and survival of sarcoma patients in France …

Simple Summary Understanding the time it takes for sarcoma patients to start treatment after
their diagnosis is essential, as a rapid onset of therapy could mean better survival chances …

Background The inactivation and replantation of autologous tumor bones are important
surgical methods for limb salvage in patients with malignancies. Currently, there are few …

The treatment of cancer has undergone a medical revolution over the last 20 years due to
the development of new drugs such as targeted therapies, immunological junction point …

Osteosarcoma (OS) is a prevalent malignancy among adolescents, commonly manifesting
during childhood and adolescence. It exhibits a high degree of malignancy, propensity for …